Dopaminergic function in the psychosis spectrum: An [18F]-DOPA imaging study in healthy individuals with auditory hallucinations

Oliver D. Howes, Paul Shotbolt, Michael Bloomfield, Kirstin Daalman, Arsime Demjaha, Kelly M.J. Diederen, Kemal Ibrahim, Euitae Kim, Philip McGuire, René S. Kahn, Iris E. Sommer

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background: The psychosis phenotype appears to exist in the population as a continuum, but it is not clear if subclinical psychotic symptoms and psychotic disorders share the same neurobiology. We investigated whether the dopaminergic dysfunction seen in psychotic disorders is also present in healthy, well-functioning people with hallucinations.Methods: We compared dopamine synthesis capacity (using 6-[18F]fluoro-L-DOPA [[18F]- DOPA] positron emission tomography imaging) in 16 healthy individuals with frequent persistent auditory verbal hallucinations (hallucinating group) with that in 16 matched controls. Results: There was no significant difference in dopamine synthesis capacity in the striatum, or its functional subdivisions, between groups and no relationship between subclinical psychotic symptom severity or schizotypal traits and dopamine synthesis capacity in the hallucinating group. Conclusions: Altered dopamine synthesis capacity is unlikely to underlie subclinical hallucinations, suggesting that although there may be a phenomenological psychosis continuum, there are distinctions at the neurobiological level.

Original languageEnglish
Pages (from-to)807-814
Number of pages8
JournalSchizophrenia Bulletin
Volume39
Issue number4
DOIs
StatePublished - 1 Jul 2013

Fingerprint

Hallucinations
Psychotic Disorders
Dopamine
Neurobiology
Positron-Emission Tomography
Phenotype
Population

Keywords

  • PET
  • aetiology
  • dopamine
  • hallucination
  • neurochemistry
  • psychosis continuum
  • schizophrenia
  • subclinical
  • symptom

Cite this

Howes, O. D., Shotbolt, P., Bloomfield, M., Daalman, K., Demjaha, A., Diederen, K. M. J., ... Sommer, I. E. (2013). Dopaminergic function in the psychosis spectrum: An [18F]-DOPA imaging study in healthy individuals with auditory hallucinations. Schizophrenia Bulletin, 39(4), 807-814. https://doi.org/10.1093/schbul/sbr195
Howes, Oliver D. ; Shotbolt, Paul ; Bloomfield, Michael ; Daalman, Kirstin ; Demjaha, Arsime ; Diederen, Kelly M.J. ; Ibrahim, Kemal ; Kim, Euitae ; McGuire, Philip ; Kahn, René S. ; Sommer, Iris E. / Dopaminergic function in the psychosis spectrum : An [18F]-DOPA imaging study in healthy individuals with auditory hallucinations. In: Schizophrenia Bulletin. 2013 ; Vol. 39, No. 4. pp. 807-814.
@article{1ac0324a367a4d2089d1e5ca3834fd50,
title = "Dopaminergic function in the psychosis spectrum: An [18F]-DOPA imaging study in healthy individuals with auditory hallucinations",
abstract = "Background: The psychosis phenotype appears to exist in the population as a continuum, but it is not clear if subclinical psychotic symptoms and psychotic disorders share the same neurobiology. We investigated whether the dopaminergic dysfunction seen in psychotic disorders is also present in healthy, well-functioning people with hallucinations.Methods: We compared dopamine synthesis capacity (using 6-[18F]fluoro-L-DOPA [[18F]- DOPA] positron emission tomography imaging) in 16 healthy individuals with frequent persistent auditory verbal hallucinations (hallucinating group) with that in 16 matched controls. Results: There was no significant difference in dopamine synthesis capacity in the striatum, or its functional subdivisions, between groups and no relationship between subclinical psychotic symptom severity or schizotypal traits and dopamine synthesis capacity in the hallucinating group. Conclusions: Altered dopamine synthesis capacity is unlikely to underlie subclinical hallucinations, suggesting that although there may be a phenomenological psychosis continuum, there are distinctions at the neurobiological level.",
keywords = "PET, aetiology, dopamine, hallucination, neurochemistry, psychosis continuum, schizophrenia, subclinical, symptom",
author = "Howes, {Oliver D.} and Paul Shotbolt and Michael Bloomfield and Kirstin Daalman and Arsime Demjaha and Diederen, {Kelly M.J.} and Kemal Ibrahim and Euitae Kim and Philip McGuire and Kahn, {Ren{\'e} S.} and Sommer, {Iris E.}",
year = "2013",
month = "7",
day = "1",
doi = "10.1093/schbul/sbr195",
language = "English",
volume = "39",
pages = "807--814",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "4",

}

Howes, OD, Shotbolt, P, Bloomfield, M, Daalman, K, Demjaha, A, Diederen, KMJ, Ibrahim, K, Kim, E, McGuire, P, Kahn, RS & Sommer, IE 2013, 'Dopaminergic function in the psychosis spectrum: An [18F]-DOPA imaging study in healthy individuals with auditory hallucinations', Schizophrenia Bulletin, vol. 39, no. 4, pp. 807-814. https://doi.org/10.1093/schbul/sbr195

Dopaminergic function in the psychosis spectrum : An [18F]-DOPA imaging study in healthy individuals with auditory hallucinations. / Howes, Oliver D.; Shotbolt, Paul; Bloomfield, Michael; Daalman, Kirstin; Demjaha, Arsime; Diederen, Kelly M.J.; Ibrahim, Kemal; Kim, Euitae; McGuire, Philip; Kahn, René S.; Sommer, Iris E.

In: Schizophrenia Bulletin, Vol. 39, No. 4, 01.07.2013, p. 807-814.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dopaminergic function in the psychosis spectrum

T2 - An [18F]-DOPA imaging study in healthy individuals with auditory hallucinations

AU - Howes, Oliver D.

AU - Shotbolt, Paul

AU - Bloomfield, Michael

AU - Daalman, Kirstin

AU - Demjaha, Arsime

AU - Diederen, Kelly M.J.

AU - Ibrahim, Kemal

AU - Kim, Euitae

AU - McGuire, Philip

AU - Kahn, René S.

AU - Sommer, Iris E.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Background: The psychosis phenotype appears to exist in the population as a continuum, but it is not clear if subclinical psychotic symptoms and psychotic disorders share the same neurobiology. We investigated whether the dopaminergic dysfunction seen in psychotic disorders is also present in healthy, well-functioning people with hallucinations.Methods: We compared dopamine synthesis capacity (using 6-[18F]fluoro-L-DOPA [[18F]- DOPA] positron emission tomography imaging) in 16 healthy individuals with frequent persistent auditory verbal hallucinations (hallucinating group) with that in 16 matched controls. Results: There was no significant difference in dopamine synthesis capacity in the striatum, or its functional subdivisions, between groups and no relationship between subclinical psychotic symptom severity or schizotypal traits and dopamine synthesis capacity in the hallucinating group. Conclusions: Altered dopamine synthesis capacity is unlikely to underlie subclinical hallucinations, suggesting that although there may be a phenomenological psychosis continuum, there are distinctions at the neurobiological level.

AB - Background: The psychosis phenotype appears to exist in the population as a continuum, but it is not clear if subclinical psychotic symptoms and psychotic disorders share the same neurobiology. We investigated whether the dopaminergic dysfunction seen in psychotic disorders is also present in healthy, well-functioning people with hallucinations.Methods: We compared dopamine synthesis capacity (using 6-[18F]fluoro-L-DOPA [[18F]- DOPA] positron emission tomography imaging) in 16 healthy individuals with frequent persistent auditory verbal hallucinations (hallucinating group) with that in 16 matched controls. Results: There was no significant difference in dopamine synthesis capacity in the striatum, or its functional subdivisions, between groups and no relationship between subclinical psychotic symptom severity or schizotypal traits and dopamine synthesis capacity in the hallucinating group. Conclusions: Altered dopamine synthesis capacity is unlikely to underlie subclinical hallucinations, suggesting that although there may be a phenomenological psychosis continuum, there are distinctions at the neurobiological level.

KW - PET

KW - aetiology

KW - dopamine

KW - hallucination

KW - neurochemistry

KW - psychosis continuum

KW - schizophrenia

KW - subclinical

KW - symptom

UR - http://www.scopus.com/inward/record.url?scp=84879368570&partnerID=8YFLogxK

U2 - 10.1093/schbul/sbr195

DO - 10.1093/schbul/sbr195

M3 - Article

C2 - 22282457

AN - SCOPUS:84879368570

VL - 39

SP - 807

EP - 814

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 4

ER -